<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02424084</url>
  </required_header>
  <id_info>
    <org_study_id>14-266-4</org_study_id>
    <nct_id>NCT02424084</nct_id>
  </id_info>
  <brief_title>Bone Microcirculation After Extracorporeal Shock Wave Therapy</brief_title>
  <official_title>Effects of Extracorporeal Shock Wave Therapy in Bone Microcirculation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In trauma surgery and hand surgery treatment strategies of none healing bone fractures aim at
      replacing pseudarthrosis by well vascularized bone and improving microcirculation. Although
      previous studies indicate that extracorporeal shock wave therapy (ESWT) can accelerate bone
      healing in case of non-union, only a few studies focused on the elucidation of its mechanisms
      of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of
      extracorporeal shock wave therapy on scaphoid bones and metacarpal and metatarsal in a human
      in-vivo setting for the first time.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in microcirculation (composite outcome measure)</measure>
    <time_frame>Baseline and 1 minute post-dose</time_frame>
    <description>Bone blood flow [arbitrary units AU]
Bone blood velocity [AU]
Tissue oxygen saturation [%]
Relative postcapillary venous filling pressure [AU] (Composite outcome measure)</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Intact Scaphoid Bone</condition>
  <condition>Intact Metacarpal Bone</condition>
  <condition>Fractured Scaphoid Bone</condition>
  <condition>Fractured Metacarpal Bone</condition>
  <arm_group>
    <arm_group_label>Intact scaphoid bone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group A (n=20): Consent-capable male and female patients ≥18 years of age who have an intact scaphoid.
Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intact metacarpal bone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metacarpal bone.
Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fractured scaphoid bone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group C (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured scaphoid.
Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fractured metacarpal bone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group D (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured metacarpal bone.
Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intact metatarsal bone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metatarsal bone.
Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)</intervention_name>
    <description>Extracorporeal Shock Wave Therapy</description>
    <arm_group_label>Intact scaphoid bone</arm_group_label>
    <arm_group_label>Intact metacarpal bone</arm_group_label>
    <arm_group_label>Fractured scaphoid bone</arm_group_label>
    <arm_group_label>Fractured metacarpal bone</arm_group_label>
    <arm_group_label>Intact metatarsal bone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Group A (n=20): Consent-capable male and female patients ≥18 years of age who have an
             intact scaphoid.

          -  Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an
             intact metacarpal bone.

          -  Group C (n=20): Consent-capable male and female patients ≥18 years of age who have a
             fractured scaphoid.

          -  Group D (n=20): Consent-capable male and female patients ≥18 years of age who have a
             fractured metacarpal bone.

        Exclusion Criteria:

          -  below 18 years of age

          -  scar tissue above scaphoid or metacarpal bone

          -  osteoporosis or comparable bone disease

          -  medication that influences bones
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tobias Kisch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Schleswig-Holstein</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tobias Kisch, MD</last_name>
    <phone>00494515004600</phone>
    <email>tobias.kisch@uksh.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Kisch, MD</last_name>
      <phone>00494515004600</phone>
      <email>tobias.kisch@uksh.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2015</study_first_submitted>
  <study_first_submitted_qc>April 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2015</study_first_posted>
  <last_update_submitted>January 28, 2017</last_update_submitted>
  <last_update_submitted_qc>January 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Tobias Kisch</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

